Latest guidance  

COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)

Latest guidance in consultation  

Endo-Sponge for treating colorectal anastomotic leakage
Self-expanding implant insertion into the intersphincteric space for faecal incontinence
High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis
Swallowable gastric balloon capsule for weight loss
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

Latest news  

  1. Innovation through HTA: theme for HTAi 2021 Annual Meeting announced
  2. Cancer patients to benefit from new histology independent treatment
  3. NICE draft guidance does not recommend siponimod for treating secondary progressive multiple sclerosis
  4. Steam treatment recommended for men with an enlarged prostate

Tweets

by @NICEcomms